Attivare Therapeutics
Massachusetts, United States · Biotechnology, Health Care, Therapeutics · 7 employees
Attivare Therapeutics, Inc. is a pre-clinical stage biotechnology company pioneering new treatments for cancer and infectious diseases through its innovative immune-activating scaffold platform, ATTimmune.
Funding history
- Funding Round — $6.6M — Dec 2025
Recent signals
- Dec 15, 2025: Raised $6.6M
See plans & pricing → Track Attivare Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.